These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 33836787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A, Gay B, Cransac A, Briant L, Coric P, Turcaud S, Laugâa P, Bouaziz S, Chazal N.
    Antiviral Res; 2019 Apr; 164():162-175. PubMed ID: 30825471
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat.
    Adamson CS, Sakalian M, Salzwedel K, Freed EO.
    Retrovirology; 2010 Apr 20; 7():36. PubMed ID: 20406463
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
    Margot NA, Gibbs CS, Miller MD.
    Antimicrob Agents Chemother; 2010 Jun 20; 54(6):2345-53. PubMed ID: 20308382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S, Louis JM, Tycko R.
    Proc Natl Acad Sci U S A; 2020 May 12; 117(19):10286-10293. PubMed ID: 32341150
    [Abstract] [Full Text] [Related]

  • 10. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457).
    Adamson CS, Waki K, Ablan SD, Salzwedel K, Freed EO.
    J Virol; 2009 May 12; 83(10):4884-94. PubMed ID: 19279107
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.
    Dang Z, Ho P, Zhu L, Qian K, Lee KH, Huang L, Chen CH.
    J Med Chem; 2013 Mar 14; 56(5):2029-37. PubMed ID: 23379607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K, Li F, Salzwedel K, Sakalian M, Wild CT, Freed EO.
    J Virol; 2006 Nov 14; 80(22):10957-71. PubMed ID: 16956950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA, Luttge BG, Soheilian F, Nagashima K, Freed EO.
    Virology; 2010 Apr 25; 400(1):137-44. PubMed ID: 20172577
    [Abstract] [Full Text] [Related]

  • 20. Identification of potent maturation inhibitors against HIV-1 clade C.
    Timilsina U, Ghimire D, Timalsina B, Nitz TJ, Wild CT, Freed EO, Gaur R.
    Sci Rep; 2016 Jun 06; 6():27403. PubMed ID: 27264714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.